Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short-term Investments (2016 - 2018)

Historic Short-term Investments for Cumberland Pharmaceuticals (CPIX) over the last 7 years, with Q4 2018 value amounting to $8.3 million.

  • Cumberland Pharmaceuticals' Short-term Investments rose 7743.65% to $8.3 million in Q4 2018 from the same period last year, while for Dec 2018 it was $8.3 million, marking a year-over-year increase of 7743.65%. This contributed to the annual value of $8.3 million for FY2018, which is 7743.65% up from last year.
  • According to the latest figures from Q4 2018, Cumberland Pharmaceuticals' Short-term Investments is $8.3 million, which was up 7743.65% from $4.7 million recorded in Q4 2017.
  • Cumberland Pharmaceuticals' Short-term Investments' 5-year high stood at $15.6 million during Q4 2016, with a 5-year trough of $4.7 million in Q4 2017.
  • For the 5-year period, Cumberland Pharmaceuticals' Short-term Investments averaged around $11.6 million, with its median value being $14.6 million (2015).
  • In the last 5 years, Cumberland Pharmaceuticals' Short-term Investments plummeted by 7009.06% in 2017 and then surged by 7743.65% in 2018.
  • Cumberland Pharmaceuticals' Short-term Investments (Quarter) stood at $14.8 million in 2014, then dropped by 1.87% to $14.6 million in 2015, then increased by 7.26% to $15.6 million in 2016, then plummeted by 70.09% to $4.7 million in 2017, then skyrocketed by 77.44% to $8.3 million in 2018.
  • Its Short-term Investments stands at $8.3 million for Q4 2018, versus $4.7 million for Q4 2017 and $15.6 million for Q4 2016.